Literature DB >> 21269415

Residual VSD closure with an ADO II device in an infant.

Sivasubramanian Ramakrishnan1, Anita Saxena, Shiv Kumar Choudhary.   

Abstract

Postoperative residual ventricular septal defects (VSDs) are often percutaneously closed using septal occluder devices. However, their use is not advisable in small infants, because of poor outcome. We describe the successful device closure of a residual muscular VSD with an Amplatzer Duct Occluder II (ADO II) device in a child weighing 4.5 kg. It appears that ADO II may be the preferable device for the closure of moderate defects in infants and small children because of its lower profile and trackability.
© 2011 Copyright the Authors. Congenital Heart Disease © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21269415     DOI: 10.1111/j.1747-0803.2010.00468.x

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  4 in total

1.  Perimembranous Ventricular Septal Defect Device Closure: Choosing Between Amplatzer Duct Occluder I and II.

Authors:  Amal El-Sisi; R Sobhy; V Jaccoub; H Hamza
Journal:  Pediatr Cardiol       Date:  2017-03-01       Impact factor: 1.655

2.  Transcatheter Closure of Residual and Iatrogenic Ventricular Septal Defects: Tertiary Center Experience and Outcome.

Authors:  Fatma A Taha; Fareed Alnozha; Osama Amoudi; Mansour Almutairi; Reda Abuelatta
Journal:  Pediatr Cardiol       Date:  2021-09-08       Impact factor: 1.655

3.  Follow-up of patients with interventional closure of ventricular septal defects with Amplatzer Duct Occluder II.

Authors:  M Kanaan; P Ewert; F Berger; S Assa; S Schubert
Journal:  Pediatr Cardiol       Date:  2014-09-02       Impact factor: 1.655

4.  The experience of transcatheter closure of postoperative ventricular septal defect after total correction.

Authors:  N'goran Yves N'da Kouakou; Jinyoung Song; June Huh; I-Seok Kang
Journal:  J Cardiothorac Surg       Date:  2019-06-11       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.